Hercules Capital, Inc. (LON:0J4M)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,594	2,653	1,954	1,416	1,407	1,202
Market Cap Growth	-10.79%	35.78%	37.96%	0.66%	17.02%	8.75%
Enterprise Value	4,125	4,026	3,215	2,637	2,279	2,136
Last Close Price	14.34	15.25	11.28	8.36	8.16	5.75
PE Ratio	13.85	12.77	7.45	17.09	11.05	7.28
PS Ratio	7.05	6.73	5.40	5.31	6.78	5.72
PB Ratio	1.65	1.67	1.38	1.22	1.46	1.27
P/TBV Ratio	1.65	1.67	1.38	1.22	1.46	1.27
P/FCF Ratio	-	-	36.93	-	14.83	7.91
P/OCF Ratio	-	-	36.45	-	14.81	7.90
EV/Sales Ratio	10.84	10.21	8.89	9.88	10.98	10.15
EV/EBITDA Ratio	12.82	12.23	10.73	12.68	14.46	12.99
EV/EBIT Ratio	12.93	12.24	10.73	12.69	14.48	13.02
EV/FCF Ratio	-	-	60.76	-	24.01	14.04
Debt / Equity Ratio	0.97	0.90	0.87	1.13	0.95	1.00
Debt / EBITDA Ratio	4.88	4.30	4.05	6.22	5.74	5.70
Debt / FCF Ratio	-	-	23.15	-	9.68	6.24
Asset Turnover	0.13	0.14	0.14	0.11	0.11	0.11
Quick Ratio	1.66	2.51	0.83	1.00	0.35	5.98
Current Ratio	1.68	2.57	1.00	1.23	0.36	7.07
Return on Equity (ROE)	12.94%	13.87%	21.07%	7.53%	13.40%	18.75%
Return on Assets (ROA)	6.64%	7.10%	7.40%	5.56%	5.10%	5.51%
Return on Capital (ROIC)	6.73%	7.21%	7.52%	5.66%	5.18%	5.58%
Return on Capital Employed (ROCE)	10.00%	10.90%	11.70%	8.40%	9.80%	8.70%
Earnings Yield	7.22%	7.92%	13.56%	5.98%	9.14%	13.84%
FCF Yield	-	-3.58%	2.71%	-24.90%	6.74%	12.65%
Dividend Yield	10.10%	8.38%	11.06%	14.20%	11.85%	16.31%
Payout Ratio	-	95.62%	67.21%	165.87%	83.47%	67.07%
Buyback Yield / Dilution	-11.65%	-11.58%	-14.34%	-9.23%	-3.28%	-10.53%
Total Shareholder Return	-1.68%	-3.20%	-3.28%	4.97%	8.57%	5.77%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.